Vogenx, Inc.
Vogenx is a clinical-stage biopharmaceutical company based in Raleigh, North Carolina, developing mizagliflozin for post-bariatric hypoglycemia, gastroparesis, and GIP-dependent Cushing's Syndrome.
SCHEDULE 13GNov 16Latest SEC filing
Nov 6Latest story
November 2026
October 2026
September 2026
August 2026
July 2026